Sam Brasch is a Partner at HealthQuest Capital, a growth equity firm focused on investing in innovative, commercial-stage healthcare companies. He brings more than 20 years of healthcare and life sciences investment experience, including prior roles as Senior Managing Director at Kaiser Permanente Ventures and positions at New Leaf and Frazier Healthcare.

Sam has led investments and served on the boards of numerous healthcare companies, including IntelyCare, Protenus, iRhythm Technologies, and Health Catalyst. His contributions to the healthcare investment industry have been recognized by GrowthCap, which named him one of the Top 25 Investors in Healthcare in 2021, and by Global Corporate Venturing, which included him on its Powerlist in 2022.

Prior to his career in healthcare investing, Sam held a management role at Medtronic. He earned a BA in Public Policy from Stanford University and an MBA in Healthcare Management from The Wharton School.